We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Merck is appealing a decision that reinstated a class-action lawsuit alleging that the company failed to warn thousands of women taking Fosamax that they were at risk for thigh fractures. Read More